Intelligence · Drug directory

Pipeline & Investigational Drugs

Investigational and clinical-stage compounds without US or EU marketing approval — linked to ClinicalTrials.gov programs and congress coverage.

Quick answer

Pipeline & investigational drugs: NovaPharmaNews tracks 1,610 pharmaceutical drugs in this segment. Investigational and clinical-stage compounds without US or EU marketing approval — linked to ClinicalTrials.gov programs and congress coverage.

1,610 drugs · Pipeline · by data quality · Page 7 of 68

  1. perflubutane

    IMAGIFY

    EMA: application withdrawn

    V08D
  2. pexidartinib

    TURALIO

    EMA: refused

    L01XE
  3. phentermine

    QSIVA

    EMA: refused

  4. pixantrone dimaleate

    PIXUVRI

    EMA: unknown

    L01DB11
  5. plazomicin (sulfate)

    ZEMDRI

    EMA: application withdrawn

  6. plitidepsin

    APLIDIN

    EMA: application withdrawn

    L01
  7. pneumococcal saccharide conjugated vaccine, adsorbed

    PREVENAR

    EMA: withdrawn

    J07AL02
  8. prepandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted)

    PREPANDRIX

    EMA: withdrawn

    J07BB02
  9. prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted)

    PREPANDEMIC INFLUENZA VACCINE (H5N1) (SURFACE ANTIGEN, INACTIVATED, ADJUVANTED) NOVARTIS VACCINES AND DIAGNOSTICS

    EMA: unknown

    J07BB02
  10. prepandemic influenza vaccine (h5n1) (whole virion, inactivated,prepared in cell culture)

    VEPACEL

    EMA: withdrawn

    J07BB01
  11. pridopidine

    NURZIGMA

    EMA: application withdrawn

    N07
  12. recombinant human c1 inhibitor

    RHUCIN

    EMA: refused

    B06C
  13. recombinant salmon calcitonin

    FORCALTONIN

    EMA: withdrawn

    H05BA01
  14. regdanvimab

    REGKIRONA

    EMA: withdrawn

    J06BD06
  15. resminostat

    KINSELBY

    EMA: unknown

    L01X
  16. retigabine

    TROBALT

    EMA: withdrawn

    N03AX21
  17. rimonabant

    ZIMULTI

    EMA: withdrawn

    A08AX01
  18. rolapitant

    VARUBY

    EMA: withdrawn

    A04AD
  19. rosiglitazone

    AVANDAMET

    EMA: unknown

    A10BD03
  20. rotavirus vaccine

    ROTASHIELD

    EMA: withdrawn

    J07BH
  21. rubitecan

    ORATHECIN

    EMA: application withdrawn

  22. ruboxistaurin

    ARXXANT

    EMA: application withdrawn

  23. sasanlimab

    ZUMRAD

    EMA: application withdrawn

    L01FF
  24. satavaptan

    AQUILDA

    EMA: application withdrawn

Frequently asked questions

How many pipeline drugs are listed?

1,610 drug profiles match this regulatory segment in our published index.

Where does approval data come from?

Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.